176 related articles for article (PubMed ID: 20919860)
21. Twice weekly Pneumocystis jiroveci pneumonia prophylaxis with trimethoprim-sulfamethoxazole in pediatric patients with acute lymphoblastic leukemia.
Agrawal AK; Chang PP; Feusner J
J Pediatr Hematol Oncol; 2011 Jan; 33(1):e1-4. PubMed ID: 21102354
[TBL] [Abstract][Full Text] [Related]
22. Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma.
Katsuya H; Suzumiya J; Sasaki H; Ishitsuka K; Shibata T; Takamatsu Y; Tamura K
Leuk Lymphoma; 2009 Nov; 50(11):1818-23. PubMed ID: 19863173
[TBL] [Abstract][Full Text] [Related]
23. Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy.
Li C; Lu F; Lei T; Yu H; Chen X; Peng S; Han S; Yang H
BMC Cancer; 2020 Aug; 20(1):742. PubMed ID: 32770971
[TBL] [Abstract][Full Text] [Related]
24. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
[TBL] [Abstract][Full Text] [Related]
25. Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients.
Wei KC; Sy C; Wu SY; Chuang TJ; Huang WC; Lai PC
Sci Rep; 2018 May; 8(1):8321. PubMed ID: 29844519
[TBL] [Abstract][Full Text] [Related]
26. Granulomatous Pneumocystis jiroveci pneumonia in a patient with diffuse large B-cell lymphoma: case report and review of the literature.
Chang H; Shih LY; Wang CW; Chuang WY; Chen CC
Acta Haematol; 2010; 123(1):30-3. PubMed ID: 19940467
[TBL] [Abstract][Full Text] [Related]
27. Late-onset Pneumocystis jirovecii pneumonia in solid organ transplant recipients.
Perez-Ordoño L; Hoyo I; Sanclemente G; Ricart MJ; Cofan F; Perez-Villa F; de la Bellacasa JP; Moreno A; Cervera C
Transpl Infect Dis; 2014 Apr; 16(2):324-8. PubMed ID: 24456244
[TBL] [Abstract][Full Text] [Related]
28. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
Wang EH; Partovi N; Levy RD; Shapiro RJ; Yoshida EM; Greanya ED
Transpl Infect Dis; 2012 Oct; 14(5):519-25. PubMed ID: 22571389
[TBL] [Abstract][Full Text] [Related]
29. Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis.
Hugle B; Solomon M; Harvey E; James A; Wadhwa A; Amin R; Bell-Peter A; Benseler S
Arthritis Care Res (Hoboken); 2010 Nov; 62(11):1661-4. PubMed ID: 20583109
[TBL] [Abstract][Full Text] [Related]
30. High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone.
Kamel S; O'Connor S; Lee N; Filshie R; Nandurkar H; Tam CS
Leuk Lymphoma; 2010 May; 51(5):797-801. PubMed ID: 20367135
[TBL] [Abstract][Full Text] [Related]
31. Pneumocystis jiroveci pneumonia in patients with non-Hodgkin's lymphoma receiving chemotherapy containing rituximab.
Chang H; Yeh HC; Su YC; Lee MH
J Chin Med Assoc; 2008 Nov; 71(11):579-82. PubMed ID: 19015057
[TBL] [Abstract][Full Text] [Related]
32. A case of pneumocystis pneumonia after cessation of secondary prophylaxis.
Quah SP; McBride M
Int J STD AIDS; 2001 Feb; 12(2):126-7. PubMed ID: 11236102
[TBL] [Abstract][Full Text] [Related]
33. Prophylaxis against Pneumocystis jirovecii pneumonia in patients with adult T-cell lymphoma/leukemia receiving anti-CC chemokine receptor 4 monoclonal antibody.
Yamasaki S; Kohno K; Kadowaki M; Takase K; Okamura S
J Infect; 2015 Dec; 71(6):700-2. PubMed ID: 26344926
[No Abstract] [Full Text] [Related]
34. The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review.
Messiaen PE; Cuyx S; Dejagere T; van der Hilst JC
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28035717
[TBL] [Abstract][Full Text] [Related]
35. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
36. A dose-escalation regimen of trimethoprim-sulfamethoxazole is tolerable for prophylaxis against Pneumocystis jiroveci pneumonia in rheumatic diseases.
Takenaka K; Komiya Y; Ota M; Yamazaki H; Nagasaka K
Mod Rheumatol; 2013 Jul; 23(4):752-8. PubMed ID: 22907597
[TBL] [Abstract][Full Text] [Related]
37. Interstitial pneumonia after autologous hematopoietic stem cell transplantation in B-cell non-hodgkin lymphoma.
Kato H; Yamamoto K; Taji H; Oki Y; Chihara D; Seto M; Kagami Y; Morishima Y
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):483-9. PubMed ID: 21978956
[TBL] [Abstract][Full Text] [Related]
38. Pneumocystis jiroveci Pneumonia in an Atypical Host.
Reinbolt RE; Alam S; Layman R; Shapiro C; Lustberg M
Clin Breast Cancer; 2012 Apr; 12(2):138-41. PubMed ID: 22133356
[No Abstract] [Full Text] [Related]
39. Incidence, clinical presentation, and outcomes of
Barreto JN; Thompson CA; Wieruszewski PM; Pawlenty AG; Mara KC; Potter AL; Tosh PK; Limper AH
Leuk Lymphoma; 2020 Nov; 61(11):2622-2629. PubMed ID: 32623928
[TBL] [Abstract][Full Text] [Related]
40. Single-day trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer.
Caselli D; Petris MG; Rondelli R; Carraro F; Colombini A; Muggeo P; Ziino O; Melchionda F; Russo G; Pierani P; Soncini E; DeSantis R; Zanazzo G; Barone A; Cesaro S; Cellini M; Mura R; Milano GM; Meazza C; Cicalese MP; Tropia S; De Masi S; Castagnola E; Aricò M;
J Pediatr; 2014 Feb; 164(2):389-92.e1. PubMed ID: 24252793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
